Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer.

Literature DB >> 28829190

Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer.

Burak Bilgin¹, Mehmet An Şendur¹, Mutlu Hızal¹, Muhammed Bülent Akıncı¹, Didem Şener Dede¹, Bulent Yalçın¹.

Abstract

Entities: Chemical Disease

Keywords: abiraterone; androgen deprivation therapy; docetaxel; prostate cancer

Year: 2017 PMID： 28829190 DOI： 10.2217/fon-2017-0270

Source DB: PubMed Journal: Future Oncol ISSN： 1479-6694 Impact factor: 3.404

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer.

Authors: Linjun Hu; Qinxin Zhao; Hongsong Bai; Chengming Xie; Xingli Shan; Dehu Lu; Yonghai Chen; Dongdong Han; Zejun Xiao; Jun Tian; Dong Wang; Xingang Bi; Nianzeng Xing
Journal: Cancer Manag Res Date: 2020-06-09 Impact factor: 3.989

1 in total